{"id":3840,"date":"2016-10-06T12:14:37","date_gmt":"2016-10-06T15:14:37","guid":{"rendered":"https:\/\/prodoctor.net\/blog\/?p=3840"},"modified":"2021-06-10T13:54:17","modified_gmt":"2021-06-10T16:54:17","slug":"anvisa-prioriza-analise-de-medicamentos-ineditos","status":"publish","type":"post","link":"https:\/\/prodoctor.net\/blog\/anvisa-prioriza-analise-de-medicamentos-ineditos\/","title":{"rendered":"Anvisa prioriza an\u00e1lise de medicamentos in\u00e9ditos"},"content":{"rendered":"<p>A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria tem dado<strong> prioridade para an\u00e1lise de medicamentos in\u00e9ditos<\/strong>\u00a0no Brasil, a fim de aumentar as op\u00e7\u00f5es de tratamento dispon\u00edveis. Com isso, <strong>drogas ou gen\u00e9ricos in\u00e9ditos poder\u00e3o entrar no mercado<\/strong> em menor tempo. No final da \u00faltima semana foram aprovados dois rem\u00e9dios e, recentemente, a Anvisa aprovou um novo produto biol\u00f3gico para o tratamento da hemofilia.<\/p>\n<h4>Pacientes com gota ter\u00e3o novo tratamento<\/h4>\n<p>O tratamento da gota passou a <strong>contar com uma alternativa<\/strong>. Os enfermos com altas taxas de \u00e1cido \u00farico no sangue agora ter\u00e3o \u00e0 disposi\u00e7\u00e3o <strong>o novo medicamento Zurampic (lesinurade)<\/strong>, cujo registro foi aprovado pelo \u00f3rg\u00e3o governamental. Ele \u00e9 indicado para o tratamento da hiperuricemia associada \u00e0 gota em combina\u00e7\u00e3o com um inibidor da xantina oxidase em pacientes acima de 18 anos.<\/p>\n<p>O medicamento ser\u00e1 fabricado pela Hovione Limited, empresa localizada na Irlanda, enquanto a titular do registro do medicamento no Brasil ser\u00e1 a Astrazeneca do Brasil Ltda.<\/p>\n<p>A terapia combinada com lesinurade e um inibidor da xantina oxidase age tanto na excre\u00e7\u00e3o quanto na produ\u00e7\u00e3o do \u00e1cido \u00farico, proporcionando uma<strong> abordagem de duplo mecanismo<\/strong> que efetivamente<strong> reduz o \u00e1cido \u00farico s\u00e9rico<\/strong>. Al\u00e9m disso, permite que um n\u00famero significativamente maior de pacientes atinjam e mantenham as metas do tratamento para o controle da enfermidade.<\/p>\n<h4>Aprovado tratamento in\u00e9dito para convuls\u00f5es em crian\u00e7as<\/h4>\n<p>Outro medicamento disponibilizado pela Anvisa foi o <strong>Inovelon (rufinamida)<\/strong>, recomendado para o tratamento auxiliar das <strong>convuls\u00f5es associadas com a S\u00edndrome de Lennox-Gastaut<\/strong> (LGS) em crian\u00e7as acima de 4 anos de idade e com mais de 18kg e em adultos.<\/p>\n<p>A nova droga ser\u00e1 fabricada pela empresa Bushu Pharmaceuticals Limited, do Jap\u00e3o, e a titular do seu registro no Brasil ser\u00e1 a empresa Esai Laborat\u00f3rios Ltda., de S\u00e3o Paulo (SP).<\/p>\n<h4>Novo produto para combater a hemofilia<\/h4>\n<p>Recentemente, a Anvisa aprovou um novo produto biol\u00f3gico para<strong> tratar adultos e crian\u00e7as com hemofilia<\/strong>. O Eloctate (alfaefmoroctocogue) \u00e9 uma prote\u00edna de a\u00e7\u00e3o prolongada, recombinante, que substitui temporariamente o Fator VIII de coagula\u00e7\u00e3o, necess\u00e1rio para o<strong> controle e a preven\u00e7\u00e3o de hemorragias<\/strong>, ausente no sangue dos pacientes.<\/p>\n<p>O Eloctate (alfaefmoroctocogue) foi aprovado para as seguintes indica\u00e7\u00f5es terap\u00eauticas: controle e preven\u00e7\u00e3o de epis\u00f3dios hemorr\u00e1gicos, manejo perioperat\u00f3rio (profilaxia cir\u00fargica) e profilaxia de rotina para <strong>prevenir ou reduzir a frequ\u00eancia de epis\u00f3dios hemorr\u00e1gicos<\/strong>. Este medicamento, contudo, n\u00e3o indicado para o tratamento da Doen\u00e7a de von Willebrand.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria tem dado prioridade para an\u00e1lise de medicamentos in\u00e9ditos\u00a0no Brasil, a fim de aumentar&#8230;<\/p>\n","protected":false},"author":3,"featured_media":19538,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_kad_blocks_custom_css":"","_kad_blocks_head_custom_js":"","_kad_blocks_body_custom_js":"","_kad_blocks_footer_custom_js":"","_kadence_starter_templates_imported_post":false,"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"footnotes":""},"categories":[415],"tags":[],"class_list":["post-3840","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medicamentos-e-farmacia"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Anvisa prioriza an\u00e1lise de medicamentos in\u00e9ditos - Blog ProDoctor<\/title>\n<meta name=\"description\" content=\"A Anvisa tem dado prioridade para an\u00e1lise de medicamentos in\u00e9ditos no Brasil, a fim de aumentar as op\u00e7\u00f5es de tratamento dispon\u00edveis.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/prodoctor.net\/blog\/anvisa-prioriza-analise-de-medicamentos-ineditos\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Anvisa prioriza an\u00e1lise de medicamentos in\u00e9ditos - Blog ProDoctor\" \/>\n<meta property=\"og:description\" content=\"A Anvisa tem dado prioridade para an\u00e1lise de medicamentos in\u00e9ditos no Brasil, a fim de aumentar as op\u00e7\u00f5es de tratamento dispon\u00edveis.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/prodoctor.net\/blog\/anvisa-prioriza-analise-de-medicamentos-ineditos\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog ProDoctor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/prodoctorsoftware\" \/>\n<meta property=\"article:published_time\" content=\"2016-10-06T15:14:37+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-06-10T16:54:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2016\/10\/medicamentos-ineditos.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"770\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Simara Laura Salgado\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@prodoctorsoft\" \/>\n<meta name=\"twitter:site\" content=\"@prodoctorsoft\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Simara Laura Salgado\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/prodoctor.net\/blog\/anvisa-prioriza-analise-de-medicamentos-ineditos\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/prodoctor.net\/blog\/anvisa-prioriza-analise-de-medicamentos-ineditos\/\"},\"author\":{\"name\":\"Simara Laura Salgado\",\"@id\":\"https:\/\/prodoctor.net\/blog\/#\/schema\/person\/390a2585fd9ba0e7315724b234e96158\"},\"headline\":\"Anvisa prioriza an\u00e1lise de medicamentos in\u00e9ditos\",\"datePublished\":\"2016-10-06T15:14:37+00:00\",\"dateModified\":\"2021-06-10T16:54:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/prodoctor.net\/blog\/anvisa-prioriza-analise-de-medicamentos-ineditos\/\"},\"wordCount\":437,\"publisher\":{\"@id\":\"https:\/\/prodoctor.net\/blog\/#organization\"},\"image\":{\"@id\":\"https:\/\/prodoctor.net\/blog\/anvisa-prioriza-analise-de-medicamentos-ineditos\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2016\/10\/medicamentos-ineditos.jpg\",\"articleSection\":[\"Medicamentos e Farm\u00e1cia\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/prodoctor.net\/blog\/anvisa-prioriza-analise-de-medicamentos-ineditos\/\",\"url\":\"https:\/\/prodoctor.net\/blog\/anvisa-prioriza-analise-de-medicamentos-ineditos\/\",\"name\":\"Anvisa prioriza an\u00e1lise de medicamentos in\u00e9ditos - Blog ProDoctor\",\"isPartOf\":{\"@id\":\"https:\/\/prodoctor.net\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/prodoctor.net\/blog\/anvisa-prioriza-analise-de-medicamentos-ineditos\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/prodoctor.net\/blog\/anvisa-prioriza-analise-de-medicamentos-ineditos\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2016\/10\/medicamentos-ineditos.jpg\",\"datePublished\":\"2016-10-06T15:14:37+00:00\",\"dateModified\":\"2021-06-10T16:54:17+00:00\",\"description\":\"A Anvisa tem dado prioridade para an\u00e1lise de medicamentos in\u00e9ditos no Brasil, a fim de aumentar as op\u00e7\u00f5es de tratamento dispon\u00edveis.\",\"breadcrumb\":{\"@id\":\"https:\/\/prodoctor.net\/blog\/anvisa-prioriza-analise-de-medicamentos-ineditos\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/prodoctor.net\/blog\/anvisa-prioriza-analise-de-medicamentos-ineditos\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/prodoctor.net\/blog\/anvisa-prioriza-analise-de-medicamentos-ineditos\/#primaryimage\",\"url\":\"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2016\/10\/medicamentos-ineditos.jpg\",\"contentUrl\":\"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2016\/10\/medicamentos-ineditos.jpg\",\"width\":770,\"height\":400,\"caption\":\"SUS incorpora medicamento para tratamento de microcefalia\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/prodoctor.net\/blog\/anvisa-prioriza-analise-de-medicamentos-ineditos\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/prodoctor.net\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Anvisa prioriza an\u00e1lise de medicamentos in\u00e9ditos\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/prodoctor.net\/blog\/#website\",\"url\":\"https:\/\/prodoctor.net\/blog\/\",\"name\":\"Blog ProDoctor\",\"description\":\"Tudo sobre o mundo da Sa\u00fade\",\"publisher\":{\"@id\":\"https:\/\/prodoctor.net\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/prodoctor.net\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/prodoctor.net\/blog\/#organization\",\"name\":\"ProDoctor Software S\/A\",\"url\":\"https:\/\/prodoctor.net\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/prodoctor.net\/blog\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2017\/01\/Logo_PDo_Lateral.png\",\"contentUrl\":\"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2017\/01\/Logo_PDo_Lateral.png\",\"width\":2014,\"height\":485,\"caption\":\"ProDoctor Software S\/A\"},\"image\":{\"@id\":\"https:\/\/prodoctor.net\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/prodoctorsoftware\",\"https:\/\/x.com\/prodoctorsoft\",\"https:\/\/www.instagram.com\/prodoctorsoftware\/\",\"https:\/\/www.linkedin.com\/company\/prodoctor-software-ltda\",\"https:\/\/www.youtube.com\/channel\/UCIWuDLsVtIpX-PEqQn1pNlw\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/prodoctor.net\/blog\/#\/schema\/person\/390a2585fd9ba0e7315724b234e96158\",\"name\":\"Simara Laura Salgado\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/prodoctor.net\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f7d63fa9b2bc65a160e3d167e24d749aab83b89ad07013427cd4a27939cc0043?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f7d63fa9b2bc65a160e3d167e24d749aab83b89ad07013427cd4a27939cc0043?s=96&d=mm&r=g\",\"caption\":\"Simara Laura Salgado\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Anvisa prioriza an\u00e1lise de medicamentos in\u00e9ditos - Blog ProDoctor","description":"A Anvisa tem dado prioridade para an\u00e1lise de medicamentos in\u00e9ditos no Brasil, a fim de aumentar as op\u00e7\u00f5es de tratamento dispon\u00edveis.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/prodoctor.net\/blog\/anvisa-prioriza-analise-de-medicamentos-ineditos\/","og_locale":"pt_BR","og_type":"article","og_title":"Anvisa prioriza an\u00e1lise de medicamentos in\u00e9ditos - Blog ProDoctor","og_description":"A Anvisa tem dado prioridade para an\u00e1lise de medicamentos in\u00e9ditos no Brasil, a fim de aumentar as op\u00e7\u00f5es de tratamento dispon\u00edveis.","og_url":"https:\/\/prodoctor.net\/blog\/anvisa-prioriza-analise-de-medicamentos-ineditos\/","og_site_name":"Blog ProDoctor","article_publisher":"https:\/\/www.facebook.com\/prodoctorsoftware","article_published_time":"2016-10-06T15:14:37+00:00","article_modified_time":"2021-06-10T16:54:17+00:00","og_image":[{"width":770,"height":400,"url":"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2016\/10\/medicamentos-ineditos.jpg","type":"image\/jpeg"}],"author":"Simara Laura Salgado","twitter_card":"summary_large_image","twitter_creator":"@prodoctorsoft","twitter_site":"@prodoctorsoft","twitter_misc":{"Escrito por":"Simara Laura Salgado","Est. tempo de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/prodoctor.net\/blog\/anvisa-prioriza-analise-de-medicamentos-ineditos\/#article","isPartOf":{"@id":"https:\/\/prodoctor.net\/blog\/anvisa-prioriza-analise-de-medicamentos-ineditos\/"},"author":{"name":"Simara Laura Salgado","@id":"https:\/\/prodoctor.net\/blog\/#\/schema\/person\/390a2585fd9ba0e7315724b234e96158"},"headline":"Anvisa prioriza an\u00e1lise de medicamentos in\u00e9ditos","datePublished":"2016-10-06T15:14:37+00:00","dateModified":"2021-06-10T16:54:17+00:00","mainEntityOfPage":{"@id":"https:\/\/prodoctor.net\/blog\/anvisa-prioriza-analise-de-medicamentos-ineditos\/"},"wordCount":437,"publisher":{"@id":"https:\/\/prodoctor.net\/blog\/#organization"},"image":{"@id":"https:\/\/prodoctor.net\/blog\/anvisa-prioriza-analise-de-medicamentos-ineditos\/#primaryimage"},"thumbnailUrl":"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2016\/10\/medicamentos-ineditos.jpg","articleSection":["Medicamentos e Farm\u00e1cia"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/prodoctor.net\/blog\/anvisa-prioriza-analise-de-medicamentos-ineditos\/","url":"https:\/\/prodoctor.net\/blog\/anvisa-prioriza-analise-de-medicamentos-ineditos\/","name":"Anvisa prioriza an\u00e1lise de medicamentos in\u00e9ditos - Blog ProDoctor","isPartOf":{"@id":"https:\/\/prodoctor.net\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/prodoctor.net\/blog\/anvisa-prioriza-analise-de-medicamentos-ineditos\/#primaryimage"},"image":{"@id":"https:\/\/prodoctor.net\/blog\/anvisa-prioriza-analise-de-medicamentos-ineditos\/#primaryimage"},"thumbnailUrl":"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2016\/10\/medicamentos-ineditos.jpg","datePublished":"2016-10-06T15:14:37+00:00","dateModified":"2021-06-10T16:54:17+00:00","description":"A Anvisa tem dado prioridade para an\u00e1lise de medicamentos in\u00e9ditos no Brasil, a fim de aumentar as op\u00e7\u00f5es de tratamento dispon\u00edveis.","breadcrumb":{"@id":"https:\/\/prodoctor.net\/blog\/anvisa-prioriza-analise-de-medicamentos-ineditos\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/prodoctor.net\/blog\/anvisa-prioriza-analise-de-medicamentos-ineditos\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/prodoctor.net\/blog\/anvisa-prioriza-analise-de-medicamentos-ineditos\/#primaryimage","url":"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2016\/10\/medicamentos-ineditos.jpg","contentUrl":"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2016\/10\/medicamentos-ineditos.jpg","width":770,"height":400,"caption":"SUS incorpora medicamento para tratamento de microcefalia"},{"@type":"BreadcrumbList","@id":"https:\/\/prodoctor.net\/blog\/anvisa-prioriza-analise-de-medicamentos-ineditos\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/prodoctor.net\/blog\/"},{"@type":"ListItem","position":2,"name":"Anvisa prioriza an\u00e1lise de medicamentos in\u00e9ditos"}]},{"@type":"WebSite","@id":"https:\/\/prodoctor.net\/blog\/#website","url":"https:\/\/prodoctor.net\/blog\/","name":"Blog ProDoctor","description":"Tudo sobre o mundo da Sa\u00fade","publisher":{"@id":"https:\/\/prodoctor.net\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/prodoctor.net\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/prodoctor.net\/blog\/#organization","name":"ProDoctor Software S\/A","url":"https:\/\/prodoctor.net\/blog\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/prodoctor.net\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2017\/01\/Logo_PDo_Lateral.png","contentUrl":"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2017\/01\/Logo_PDo_Lateral.png","width":2014,"height":485,"caption":"ProDoctor Software S\/A"},"image":{"@id":"https:\/\/prodoctor.net\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/prodoctorsoftware","https:\/\/x.com\/prodoctorsoft","https:\/\/www.instagram.com\/prodoctorsoftware\/","https:\/\/www.linkedin.com\/company\/prodoctor-software-ltda","https:\/\/www.youtube.com\/channel\/UCIWuDLsVtIpX-PEqQn1pNlw"]},{"@type":"Person","@id":"https:\/\/prodoctor.net\/blog\/#\/schema\/person\/390a2585fd9ba0e7315724b234e96158","name":"Simara Laura Salgado","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/prodoctor.net\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f7d63fa9b2bc65a160e3d167e24d749aab83b89ad07013427cd4a27939cc0043?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f7d63fa9b2bc65a160e3d167e24d749aab83b89ad07013427cd4a27939cc0043?s=96&d=mm&r=g","caption":"Simara Laura Salgado"}}]}},"taxonomy_info":{"category":[{"value":415,"label":"Medicamentos e Farm\u00e1cia"}]},"featured_image_src_large":["https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2016\/10\/medicamentos-ineditos.jpg",770,400,false],"author_info":{"display_name":"Simara Laura Salgado","author_link":"https:\/\/prodoctor.net\/blog\/author\/simara-laura\/"},"comment_info":0,"category_info":[{"term_id":415,"name":"Medicamentos e Farm\u00e1cia","slug":"medicamentos-e-farmacia","term_group":0,"term_taxonomy_id":415,"taxonomy":"category","description":"","parent":0,"count":132,"filter":"raw","cat_ID":415,"category_count":132,"category_description":"","cat_name":"Medicamentos e Farm\u00e1cia","category_nicename":"medicamentos-e-farmacia","category_parent":0}],"tag_info":false,"_links":{"self":[{"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/posts\/3840","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/comments?post=3840"}],"version-history":[{"count":5,"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/posts\/3840\/revisions"}],"predecessor-version":[{"id":19539,"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/posts\/3840\/revisions\/19539"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/media\/19538"}],"wp:attachment":[{"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/media?parent=3840"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/categories?post=3840"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/tags?post=3840"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}